Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics.
D000818:Animals; D019149:Bioreactors; D015139:Blotting, Southern; D017931:DNA Primers; D000229:Dependovirus / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay; D004921:Erythropoietin / Q000032:analysis / Q000097:blood / Q000235:genetics / Q000493:pharmacokinetics; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D006400:Hematocrit; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D016133:Polymerase Chain Reaction; D011994:Recombinant Proteins / Q000032:analysis / Q000097:blood; D012469:Salivary Glands / Q000502:physiology*; D014018:Tissue Distribution; D001616:beta-Galactosidase / Q000235:genetics
D017931:DNA Primers; D011994:Recombinant Proteins; D004921:Erythropoietin; D001616:beta-Galactosidase